5[5]Cho MH,Lee HS,Choe BH,et al.Interleukin-8 and tumor necrosis factor-alpha are increased in minimal change disease but not alter albumin permeability.Am J Nephrol,2003,23 (4):260-266.
7[7]Cappelli G,Ballestri M,Perrone S,et al.Biofilms invade nephrology:effects in hemodialysis.Blood Purif,2000,18:224-230.
8[8]Lain C,Macdougall,Angela C.Erythropoietin resistance:the role of inflammation and pro-inflammatory cytokines.Nephrol Dial Transplant,2002,17(2):139-143.
9[9]Tanaka E.Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.J Clin PharmTher,1999,24(2):8.
2Ward RA. Ultrapure dialysate: a desirable and achievable goal for routine hemodialysis. Semin Dial, 2000, 13:378-380.
3Lonnemann G. Chronic inflammation in hemodialysis: the role of contaminated dialysate. Blood Purif, 2000, 18:214-223.
4Schiffl H, Lang SM, Stratakis D, et al. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant, 2001, 16:1863-1869.
6Stenvinkel P. The role of inflammation in the anaemia of endstage renal disease. Nephrol Dial Transplant, 2001, 16 Suppl 7:36-40.
7Sitter T, Bergner A, Schiffl H. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant, 2000, 15:1207-1211.
8Schiffl H, Lang SM, Bergner A. Ultrapure dialysate reduces dose of recombinant human erythropoietin. Nephron, 1999, 83:278 -279.
9Cappelli G, Ballestri M, Perrone S, et al. Biofilms invade nephrology: effects in hemodialysis. Blood Purif, 2000, 18:224-230.?A?A
10Canaud B, Bosc JY, Leray H, et al. Microbiologic purity of dialysate: rationale and technical aspects. Blood Purif, 2000,18:200-213.
